Tumor Profiling Studies Illuminate Nuances Across Malignancies

November 21, 2022Megan HollaschMolecular and immune landscapes for solid tumors are constantly evolving as precision medicine techniques become more sensitive and next-generation sequencing methods ar

Updated on: October 17,2023 205

Tumor Profiling Studies Illuminate Nuances Across Malignancies

November 21, 2022Megan HollaschMolecular and immune landscapes for solid tumors are constantly evolving as precision medicine techniques become more sensitive and next-generation sequencing methods ar

Updated on:October 17,2023 205

More breast cancer patients can choose smaller surgery

by Carla K. JohnsonA technician displays images of a mammogram scan on a computer screen at a hospital in Odessa, Texas, on Wednesday, Oct. 20, 2021. A study discussed Friday, Dec. 9, 2022, at the San

Updated on: December 22,2023 9

More breast cancer patients can choose smaller surgery

by Carla K. JohnsonA technician displays images of a mammogram scan on a computer screen at a hospital in Odessa, Texas, on Wednesday, Oct. 20, 2021. A study discussed Friday, Dec. 9, 2022, at the San

Updated on:December 22,2023 9

Daratumumab Plus Induction Therapy Reduces Stem Cell Yield in Multiple Myeloma

June 9, 2023Tony Berberabe, MPHThe addition of daratumumab to frontline induction therapy prior to peripheral blood stem cell collection reduced the number of patients with newly diagnosed multiple my

Updated on: October 12,2023 41

Daratumumab Plus Induction Therapy Reduces Stem Cell Yield in Multiple Myeloma

June 9, 2023Tony Berberabe, MPHThe addition of daratumumab to frontline induction therapy prior to peripheral blood stem cell collection reduced the number of patients with newly diagnosed multiple my

Updated on:October 12,2023 41

Breast-conserving treatment without surgery not supported at this time

by NRG OncologyResults from NRG Oncology's BR005 study show that breast-conserving treatment without surgery cannot be recommended, based on the study criteria of clinical complete response, radio

Updated on: December 22,2023 19

Breast-conserving treatment without surgery not supported at this time

by NRG OncologyResults from NRG Oncology's BR005 study show that breast-conserving treatment without surgery cannot be recommended, based on the study criteria of clinical complete response, radio

Updated on:December 22,2023 19

Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

by Roswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to hav

Updated on: December 20,2023 10

Low income linked to high recurrence risk, poorer survival in women with ER-positive breast cancer

by Roswell Park Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to hav

Updated on:December 20,2023 10

Allogeneic HCT after primary induction failure beneficial in leukemia

by Elana GotkineFor patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benef

Updated on: December 26,2023 16

Allogeneic HCT after primary induction failure beneficial in leukemia

by Elana GotkineFor patients with acute myeloid leukemia (AML), immediate allogeneic hematopoietic stem cell transplantation (HCT) after primary induction failure (PIF) offers long-term survival benef

Updated on:December 26,2023 16

Cancer therapy may be aided by induced macropinocytosis, a rare form of cell death

by Jeff Hansen,University of Alabama at BirminghamMohammad Athar. Credit: UABIn laboratory experiments, a metabolic inhibitor was able to kill a variety of human cancer cells of the skin, breast

Updated on: December 22,2023 21

Cancer therapy may be aided by induced macropinocytosis, a rare form of cell death

by Jeff Hansen,University of Alabama at BirminghamMohammad Athar. Credit: UABIn laboratory experiments, a metabolic inhibitor was able to kill a variety of human cancer cells of the skin, breast

Updated on:December 22,2023 21

AI tackles the ABCD of skin cancer

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainNew research from India has shown how machine learning, colloquially known as artificial intelligence or AI, could improve the earl

Updated on: January 04,2024 9

AI tackles the ABCD of skin cancer

by David Bradley,InderscienceCredit: Unsplash/CC0 Public DomainNew research from India has shown how machine learning, colloquially known as artificial intelligence or AI, could improve the earl

Updated on:January 04,2024 9

Prexigebersen–Based Therapy Induces High CR/CRi Rates in Newly Diagnosed, Relapsed/Refractory AML

August 1, 2023Caroline SeymourPrexigebersen in combination with decitabine and venetoclax demonstrated potent antitumor activity when used in the treatment of patients with newly diagnosed and relapse

Updated on: October 12,2023 26

Prexigebersen–Based Therapy Induces High CR/CRi Rates in Newly Diagnosed, Relapsed/Refractory AML

August 1, 2023Caroline SeymourPrexigebersen in combination with decitabine and venetoclax demonstrated potent antitumor activity when used in the treatment of patients with newly diagnosed and relapse

Updated on:October 12,2023 26

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers

Updated on: December 22,2023 12

Novel genetic signature that can predict some kinds of breast cancer is identified

by Maria Fernanda Ziegler,FAPESPBlood vessels from the retina of a mouse with retinopathy, normal and pathological vessels stained green and red respectively. Credit: Ricardo GiordanoResearchers

Updated on:December 22,2023 12

Scientists find strong evidence for testing newly developed drug in liver cancer

byVirginia Commonwealth UniversityDevanand Sarkar, M.B.B.S., Ph.D. Credit: VCU Massey Cancer CenterResearchers at VCU Massey Cancer Center have published new study findings that establish ration

Updated on: December 27,2023 10

Scientists find strong evidence for testing newly developed drug in liver cancer

byVirginia Commonwealth UniversityDevanand Sarkar, M.B.B.S., Ph.D. Credit: VCU Massey Cancer CenterResearchers at VCU Massey Cancer Center have published new study findings that establish ration

Updated on:December 27,2023 10

Acalabrutinib Approved in China for Chronic Lymphocytic Leukemia

September 5, 2023Kristi RosaThe National Medical Products Administration in China has approved acalabrutinib for use in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma w

Updated on: October 12,2023 87

Acalabrutinib Approved in China for Chronic Lymphocytic Leukemia

September 5, 2023Kristi RosaThe National Medical Products Administration in China has approved acalabrutinib for use in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma w

Updated on:October 12,2023 87